Clinical Features of Respiratory Tract Infections Associated with Parechovirus A in Pediatric Patients
Overview
This study investigates the role of parechovirus A (PeV-A) in respiratory tract infections (RTIs) among pediatric patients. Findings indicate that PeV-A is often co-detected with other viruses and is primarily associated with upper RTIs such as pharyngitis and tonsillitis, without impacting disease severity in cases of co-infection.
Background
Respiratory tract infections are a significant cause of morbidity in children, and understanding the role of various pathogens is crucial for effective management. Parechovirus A (PeV-A) has emerged as a potential contributor to RTIs, yet its clinical significance, particularly in hospitalized children, remains poorly defined. This study aims to clarify the association between PeV-A and RTIs in pediatric populations.
Data Highlights
Study Group
PeV-A Detection
Co-detections
Clinical Manifestations
Hospital Study
4.6% (15/323) single PeV-A
95.4% (308/323) with other viruses
Pharyngitis, tonsillitis
Day-Care Study
30 children with PeV-A
8/10 with single PeV-A
Pharyngitis, tonsillitis
Key Findings
Single PeV-A detection was associated with pharyngitis and tonsillitis in children.
95.4% of PeV-A detections in hospitalized children were co-detected with other viruses, primarily RSV and HRV.
Multivariable logistic regression indicated a strong association between single PeV-A and upper RTIs (OR 11.3).
Presence of PeV-A did not affect clinical outcomes in children with co-detected RSV and HRV.
PeV-A was detected in 30 children attending day-care, with a significant number presenting with upper RTI symptoms.
Clinical Implications
Highlight the necessity for additional research on PeV-A's role in severe infections.
Conclusion
The findings highlight the need for careful interpretation of PeV-A detection in pediatric RTIs, emphasizing its role in mild infections while cautioning against over-attributing causality in more severe cases involving multiple pathogens.
